Generate a tailored SOP for Dr. Sameer Greenall. Improve your application with a focused, well-structured draft.
Sameer Greenall is a Medical Research Fellow at the Blood Cancer Therapeutics laboratory, affiliated with Monash University. As a trained immunopathologist, he has developed expertise in the analysis and application of antibody and small molecule-based therapeutics to address aggressive brain and liver cancers that exhibit resistance to treatments. His work includes extensive experience with antibody-receptor therapeutics, focusing on the discovery of new targets for Burkitt's lymphoma and liver cancer. He is particularly interested in two primary research streams: the identification of new druggable therapeutic targets aimed at improving patient treatment responses for Burkitt's lymphoma, and the discovery of effective therapeutic combinations to combat liver cancer. With a strong commitment to education, Sameer has a passionate approach toward mentoring students and has supervised several honors students, contributing to their academic success and growth. He is actively involved in research that aligns with the United Nations Sustainable Development Goals, particularly emphasizing education and health advancements.
Monash University • Melbourne
Conducts research in the field of blood cancer therapeutics, focusing on antibody-based and small molecule inhibitors.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.